Cryoport to Present at the Source Capital Group's 2016 Disruptive Growth & Healthcare Conference

February 4, 2016 | By Kate Covalt

Irvine, CA, Feb. 4, 2016 - Cryoport, Inc. (NASDAQ: CYRX), ("Company"), the world’s leading cryogenic logistics company, today announced that Jerrell Shelton, Chief Executive Officer of Cryoport, Inc, will present at the Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference to be held at the Convene, 730 Third Avenue in New York City on Wednesday, February 10, 2016 at 10:15am ET.

The event will be available via live audio webcast and archived replay accessible here.  

About Cryoport, Inc.

Cryoport is the premier provider of cryogenic logistics solutions to the life sciences industry through its purpose-built proprietary packaging, information technology and specialized cold chain logistics expertise. The Company provides leading edge logistics solutions for biologic materials, such as immunotherapies, stem cells, CAR-T cells and reproductive cells for clients worldwide. Cryoport actively supports points-of-care, CRO's, central laboratories, pharmaceutical companies, contract manufacturers and university researchers. For more information, visit

To download Cryoport's investor relations app, which offers access to SEC documents, press releases, videos, audiocasts and more, please click to download from your iPhone and iPad or  Android mobile device.

Cryoport Investor Contacts:
Todd Fromer / Garth Russell /
P: 1 212-682-6300